These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1189 related items for PubMed ID: 16019358

  • 1. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, Gibson MJ.
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [Abstract] [Full Text] [Related]

  • 2. Progestins abrogate estrogen-induced changes in the insulin-like growth factor axis.
    Heald A, Selby PL, White A, Gibson JM.
    Am J Obstet Gynecol; 2000 Sep; 183(3):593-600. PubMed ID: 10992179
    [Abstract] [Full Text] [Related]

  • 3. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG, Leung KC, Sullivan D, Reutens AT, Ho KK.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [Abstract] [Full Text] [Related]

  • 4. Effects of conjugated equine estrogen vs. raloxifene on serum insulin-like growth factor-i and insulin-like growth factor binding protein-3: a 2-year, double-blind, placebo-controlled study.
    Duschek EJ, de Valk-de Roo GW, Gooren LJ, Netelenbos C.
    Fertil Steril; 2004 Aug; 82(2):384-90. PubMed ID: 15302288
    [Abstract] [Full Text] [Related]

  • 5. Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
    Kwok S, Selby PL, McElduff P, Laing I, Mackness B, Mackness MI, Prais H, Morgan J, Yates AP, Durrington PN, Sci FM.
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):760-7. PubMed ID: 15579192
    [Abstract] [Full Text] [Related]

  • 6. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
    Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR.
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):721-7. PubMed ID: 12917202
    [Abstract] [Full Text] [Related]

  • 7. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A, Voskuil DW, Bueno de Mesquita HB, Kaaks R, van Noord PA, Keinan-Boker L, van Gils CH, Peeters PH.
    Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
    [Abstract] [Full Text] [Related]

  • 8. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
    Amin S, Riggs BL, Atkinson EJ, Oberg AL, Melton LJ, Khosla S.
    J Bone Miner Res; 2004 Jul; 19(7):1075-83. PubMed ID: 15176989
    [Abstract] [Full Text] [Related]

  • 9. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF, Odar-Cederlöf I, Ericsson F, Brismar K.
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [Abstract] [Full Text] [Related]

  • 10. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
    Gravholt CH, Chen JW, Oxvig C, Overgaard MT, Christiansen JS, Frystyk J, Flyvbjerg A.
    Growth Horm IGF Res; 2006 Sep; 16(5-6):332-9. PubMed ID: 17067837
    [Abstract] [Full Text] [Related]

  • 11. The IGF system in the neonatal ovine uterus.
    Hayashi K, Carpenter KD, Welsh TH, Burghardt RC, Spicer LJ, Spencer TE.
    Reproduction; 2005 Mar; 129(3):337-47. PubMed ID: 15749960
    [Abstract] [Full Text] [Related]

  • 12. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 13. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
    Lindgren BF, Segovia B, Lassarre C, Binoux M, Gourmelen M.
    Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
    [Abstract] [Full Text] [Related]

  • 14. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR, Stuckey BG, Norman RJ, Papalia MA, Drillich A, Bell RJ.
    Menopause; 2008 Sep; 15(6):1065-9. PubMed ID: 18806686
    [Abstract] [Full Text] [Related]

  • 15. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S, Riggs BL, Melton LJ, Achenbach SJ, Atkinson EJ, Khosla S.
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [Abstract] [Full Text] [Related]

  • 16. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H, Stevenson J.
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [Abstract] [Full Text] [Related]

  • 17. Plasma insulin-like growth factor-I and its binding proteins 1 and 3 during continuous nonoral and oral combined hormone replacement therapy.
    Raudaskoski T, Knip M, Laatikainen T.
    Menopause; 1998 Jun; 5(4):217-22. PubMed ID: 9872487
    [Abstract] [Full Text] [Related]

  • 18. Altered expression of IGFs and IGF-binding proteins during intrauterine growth restriction in guinea pigs.
    Carter AM, Kingston MJ, Han KK, Mazzuca DM, Nygard K, Han VK.
    J Endocrinol; 2005 Jan; 184(1):179-89. PubMed ID: 15642794
    [Abstract] [Full Text] [Related]

  • 19. Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins.
    Feldmann B, Jehle PM, Mohan S, Lang GE, Lang GK, Brueckel J, Boehm BO.
    Growth Horm IGF Res; 2000 Feb; 10(1):53-9. PubMed ID: 10753593
    [Abstract] [Full Text] [Related]

  • 20. The insulin-like growth factor-I system and hormone replacement therapy.
    Cardim HJ, Lopes CM, Giannella-Neto D, da Fonseca AM, Pinotti JA.
    Fertil Steril; 2001 Feb; 75(2):282-7. PubMed ID: 11172828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.